Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Couch

Showing results (201-210 of 243) with videos related to

Pageof 25
Sort By:
Human Vaccines & Immunotherapeutics|June 9, 2016
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virusAnurodh Shankar Agrawal, Xinrong Tao, Abdullah Algaissi, et al.
Developments in Biological Standardization|June 1, 1977
An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteersB R Murphy, L J Markoff, R M Chanock, et al.
Journal of Clinical Microbiology|October 1, 1994
Development and application of an enzyme immunoassay for coronavirus OC43 antibody in acute respiratory illnessE P Gill, E A Dominguez, S B Greenberg, et al.
Journal of Virology|January 16, 2015
Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and diseaseAnurodh Shankar Agrawal, Tania Garron, Xinrong Tao, et al.
The Journal of Infectious Diseases|April 1, 1982
Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirusS B Greenberg, M W Harmon, R B Couch, et al.
Plos One|December 15, 2012
Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humansRobert B Couch, William K Decker, Budi Utama, et al.
Plos One|April 27, 2012
Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virusChien-Te Tseng, Elena Sbrana, Naoko Iwata-Yoshikawa, et al.
Journal of Clinical Microbiology|October 1, 1994
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adultsW A Keitel, R B Couch, T R Cate, et al.
Clinical and Diagnostic Laboratory Immunology|September 1, 1996
Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderlyW A Keitel, T R Cate, R L Atmar, et al.
Plos One|June 28, 2013
Human H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or SpreadShelly Gulati, David F Smith, Richard D Cummings, et al.
Pageof 25

Showing results (201-210 of 243) with videos related to

Sort By:
Pageof 25
Human Vaccines & Immunotherapeutics|June 9, 2016
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virusAnurodh Shankar Agrawal, Xinrong Tao, Abdullah Algaissi, et al.
Developments in Biological Standardization|June 1, 1977
An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteersB R Murphy, L J Markoff, R M Chanock, et al.
Journal of Clinical Microbiology|October 1, 1994
Development and application of an enzyme immunoassay for coronavirus OC43 antibody in acute respiratory illnessE P Gill, E A Dominguez, S B Greenberg, et al.
Journal of Virology|January 16, 2015
Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and diseaseAnurodh Shankar Agrawal, Tania Garron, Xinrong Tao, et al.
The Journal of Infectious Diseases|April 1, 1982
Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirusS B Greenberg, M W Harmon, R B Couch, et al.
Plos One|December 15, 2012
Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humansRobert B Couch, William K Decker, Budi Utama, et al.
Plos One|April 27, 2012
Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virusChien-Te Tseng, Elena Sbrana, Naoko Iwata-Yoshikawa, et al.
Journal of Clinical Microbiology|October 1, 1994
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adultsW A Keitel, R B Couch, T R Cate, et al.
Clinical and Diagnostic Laboratory Immunology|September 1, 1996
Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderlyW A Keitel, T R Cate, R L Atmar, et al.
Plos One|June 28, 2013
Human H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or SpreadShelly Gulati, David F Smith, Richard D Cummings, et al.
Pageof 25